First-trimester biochemical markers for Down syndrome

Prenatal Diagnosis

Volumn 19, Issue 1, 1999, Pages 8-11

  Casals, Elena ^a   Aibar, Carlos ^b   Martínez, Josep Maria ^b   Borrell, Antoni ^b   Soler, Anna ^b   Ojuel, Julia ^b   Ballesta, Antonio Manuel ^b   Fortuny, Albert ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

hCG; Down syndrome; f hCG; First trimester; PAPP A

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 0032948121     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199901)19:1<8::AID-PD460>3.0.CO;2-1     Document Type: Article

References (15)

1. Brambati, B., Tului, L., Bonacchi, I., Shrimanker, K., Suzuki, Y., Grudzinskas, J.G. (1994). Serum PAPP-A and free beta hCG are first-trimester screening markers for Down syndrome, Prenat. Diagn., 14, 1043-1047.
2. Brizot, M.L., Snijders, R.J.M., Butler, J., Bersinger, N.A., Nicolaides, K.H. (1995). Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy, Br. J. Obstet. Gynaecol., 102, 127-132.
3. Casals, E., Fortuny, A., Grudzinskas, J.G., Suzuki, Y., Teisner, B., Comas, C., Sanllehy, C., Ojuel, J., Borrell, A., Soler, A., Ballesta, A.M. (1996). First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP and βhCG, Prenat. Diagn., 16, 405-410.
4. Cuckle, H. (1994). Screening at 11-14 weeks' gestation: the role of established markers and PAPP-A. In: Grudzinskas, J.G., Chard, T., Chapman, M.G. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge University Press, 311-323.
5. Haddow, J.E., Palomaki, G.E., Knight, G.J., Williams, J., Miller, W.A., Johnson, A. (1998). Screening of maternal serum for fetal Down's Syndrome in the first trimester, N. Engl. J. Med., 338, 955-961.
6. Hurley, P.A., Ward, R.H.T., Teisner, B., Iles, R.K., Lucas, M., Grudzinskas, J.G. (1993). Serum PAPP-A measurements in first-trimester screening for Down syndrome, Prenat. Diagn., 13, 903-908.
7. Macintosh, M.C.M., Iles, I., Teisner, B., Sharma, K., Chard, T., Grudzinskas, J.G., Ward, R.H.T., Müller, F. (1994). Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks, Prenat. Diagn., 14, 203-208.
8. Macri, J.N., Spencer, K., Aitken, D., Graver, K., Buchanan, P.D., Müller, F., Boué, A. (1993). First-trimester free beta (hCG) screening for Down syndrome, Prenat. Diagn., 13, 537-562.
9. Meisser, A., Geinoz, A., Bischof, P. (1988). In vitro effects of pregnancy-associated plasma: artifacts due to heparin, Biol. Reprod., 39, 373-378.
10. Ren, S.G., Braunstein, G.D. (1992). Human chorionic gonadotropin, Seminars Reproduct. Endocrinol., 10, 95-105.
11. Schindler, A.M., Bordignon, P., Bischof, P. (1984). Immunohistochemical localization of pregnancy-associated plasma protein-A in decidua and trophoblast. Comparison with hCG and fibrin, Placenta, 5, 227-236.
12. Sinosich, M.J. (1988). Past, present and future of pregnancy-associated plasma protein-A (PAPP-A). In: Tomoda, Y., Mizutani, S., Marita, O., Klopper, A. (Eds). Placental and Endometrial Proteins, The Netherlands: VSP, 11-18.
13. Sjoberg, J., Wahlstrom, T., Seppale, M., Rutanen, E.M., Koinstinen, R., Koskimies, A.I., Sinosich, M.J., Teisner, B., Grudzinskas, J.G. (1986). Seminal plasma levels of PPAP-A in normospermic and oligospermic men and tissue localization of PAPP-A in the male genital tract, Arch. Androl., 14, 253-261.
14. Wald, N.J., George, L., Smith, D., Densem, J.W., Petterson, K. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy, Br. J. Obstet. Gynaecol., 103, 407-412.
15. Van Lith, J.M.M. (1992). First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders, Prenat. Diagn., 12, 495-504.